
NYSE:RVTY
This summary was created by AI, based on 1 opinions in the last 12 months.
Revvity (RVTY-N) is gaining recognition in the life sciences sector, marking a significant turnaround after a period of stagnation. The company's stock performance improved notably last October, leading to an upward revision of their full-year earnings forecast. With a price-to-earnings ratio of 21, Revvity is currently considered the most affordable option within its industry. This feedback highlights the potential for growth, positioning Revvity favorably against its peers. Experts express optimism about Revvity's prospects as it continues to enhance its performance and regain investor confidence.
Revvity is a American stock, trading under the symbol RVTY (previously RVTY-N on Stockchase) on the New York Stock Exchange (RVTY). It is usually referred to as NYSE:RVTY or RVTY
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on RVTY (previously RVTY-N on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is BUY. Read the latest stock experts' ratings for Revvity.
Revvity was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Revvity.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Revvity.
Revvity is covered by Stockchase experts and is worth watching.
On 2026-09-02, Revvity (RVTY) stock closed at a price of $130.94.
A life sciences company. After years of going nowhere, they finally posted good numbers last October and raised their full-year earnings forecast. Trades at 21x PE, the cheapest in the sector.